Inventor
SIMPSON DAVID M
US16 patents
⚠️ This page may combine multiple inventors who share the name “SIMPSON DAVID M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IGEN INC
4 patentsUS5597573AJan 28, 1997
Lipid-A analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
IGEN INC28 citations92
US5593969AJan 14, 1997
Lipid-A analogs: monosaccharide and dissaccharide compounds for inhibiting binding of lipid A receptors to lipid A receptors
IGEN INC23 citations92
US5891648AApr 6, 1999
Reaction-based selection for expression of and concentration of catalytic moieties
IGEN INC6 citations73
US5631137AMay 20, 1997
Reaction-based selection for expression of and concentration of catalytic moieties
IGEN INC3 citations62
IGEN INT INC
4 patentsUS6258360B1Jul 10, 2001
Prodrugs activated by targeted catalytic proteins
IGEN INT INC24 citations90
US6702705B1Mar 9, 2004
Prodrugs activated by targeted catalytic proteins
IGEN INT INC11 citations72
US6177270B1Jan 23, 2001
Reaction-based selection for expression of and concentration of catalytic moieties
IGEN INT INC2 citations62
US6121007ASep 19, 2000
Reaction-based selection for expression of and concentration of catalytic moieties
IGEN INT INC2 citations62
UNION CARBIDE CHEM PLASTIC
2 patentsWELLSTAT THERAPEUTICS CORP
2 patentsUS10934284B2Mar 2, 2021
Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
WELLSTAT THERAPEUTICS CORP2 citations70
US10030015B2Jul 24, 2018
Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
WELLSTAT THERAPEUTICS CORP3 citations68